Analysis of single-cell sequencing in mouse HCC models and human HCC organoids suggested that this difference may be due to METTL1-mediated accumulation of PMN-MDSCs following insufficient radio frequency treatment, which suppresses antitumor immunity and promotes HCC progression [105]. The gene discussed is METTL1; the disease is hepatocellular carcinoma.